$OGEN
ORAGENICS INC

2021 Form 10-K Financial Statement

#000149315222007664 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $86.99K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.272M $1.196M $4.534M
YoY Change 16.28% 33.2% 20.67%
% of Gross Profit
Research & Development $10.59M $3.350M $22.11M
YoY Change -52.12% 21.39% 82.4%
% of Gross Profit
Depreciation & Amortization $41.24K $12.86K $51.71K
YoY Change -20.25% -29.65% -17.42%
% of Gross Profit
Operating Expenses $15.86M $4.549M $26.64M
YoY Change -40.48% 24.36% 67.79%
Operating Profit -$15.77M
YoY Change
Interest Expense $60.09K $7.780K $78.60K
YoY Change -23.55% -87.25% -74.86%
% of Operating Profit
Other Income/Expense, Net -$690.00 -$600.00 -$610.00
YoY Change 13.11% 140.0% -46.96%
Pretax Income -$15.71M -$4.409M -$26.43M
YoY Change -40.56% 22.57% 69.8%
Income Tax
% Of Pretax Income
Net Earnings -$15.71M -$4.409M -$26.43M
YoY Change -40.56% 22.57% 69.8%
Net Earnings / Revenue -18061.4%
Basic Earnings Per Share -$8.09
Diluted Earnings Per Share -$139.1K -$64.83K -$467.5K
COMMON SHARES
Basic Shares Outstanding 1.943M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.27M $17.64M $17.64M
YoY Change 54.57% -3.44% -3.44%
Cash & Equivalents $27.27M $17.64M $17.64M
Short-Term Investments
Other Short-Term Assets $434.7K $343.1K $343.1K
YoY Change 26.69% -39.81% -39.81%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $27.71M $17.98M $17.98M
YoY Change 54.08% -4.54% -4.54%
LONG-TERM ASSETS
Property, Plant & Equipment $523.6K $697.9K $697.9K
YoY Change -24.97% -23.7% -23.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $523.6K $697.9K $697.9K
YoY Change -24.97% -23.7% -23.7%
TOTAL ASSETS
Total Short-Term Assets $27.71M $17.98M $17.98M
Total Long-Term Assets $523.6K $697.9K $697.9K
Total Assets $28.23M $18.68M $18.68M
YoY Change 51.13% -5.43% -5.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $855.0K $940.0K $330.4K
YoY Change 158.79% -39.02% -72.63%
Accrued Expenses $286.9K $176.9K $783.5K
YoY Change -63.39% 7.15% 56.93%
Deferred Revenue
YoY Change
Short-Term Debt $303.4K $228.2K $228.2K
YoY Change 32.94% 58.65% 58.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.445M $1.342M $1.342M
YoY Change 7.68% -27.47% -27.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $299.5K $493.8K $493.8K
YoY Change -39.34% -26.38% -26.38%
Total Long-Term Liabilities $299.5K $493.8K $493.8K
YoY Change -39.34% -26.38% -26.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.445M $1.342M $1.342M
Total Long-Term Liabilities $299.5K $493.8K $493.8K
Total Liabilities $1.745M $1.836M $1.836M
YoY Change -4.97% -27.18% -27.18%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.49M $16.84M $16.84M
YoY Change
Total Liabilities & Shareholders Equity $28.23M $18.68M $18.68M
YoY Change 51.13% -5.43% -5.43%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$15.71M -$4.409M -$26.43M
YoY Change -40.56% 22.57% 69.8%
Depreciation, Depletion And Amortization $41.24K $12.86K $51.71K
YoY Change -20.25% -29.65% -17.42%
Cash From Operating Activities -$13.47M -$3.632M -$16.95M
YoY Change -20.54% -7.75% 30.28%
INVESTING ACTIVITIES
Capital Expenditures -$43.88K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$43.88K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.14M 11.23M 16.32M
YoY Change 41.75% -15363.12% 47.1%
NET CHANGE
Cash From Operating Activities -13.47M -3.632M -16.95M
Cash From Investing Activities -43.88K 0.000
Cash From Financing Activities 23.14M 11.23M 16.32M
Net Change In Cash 9.626M 7.596M $0.00
YoY Change -288.77% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$13.47M -$3.632M -$16.95M
Capital Expenditures -$43.88K $0.00
Free Cash Flow -$13.43M -$3.632M -$16.95M
YoY Change -20.8% -7.42% 30.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
USD
CY2021 OGEN Stock Issued For Purchase
StockIssuedForPurchase
USD
CY2021 OGEN Forgiveness Of Paycheck Protection Program Loan And Accrued Interest
ForgivenessOfPaycheckProtectionProgramLoanAndAccruedInterest
USD
CY2020 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2020 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q4 OGEN Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
USD
CY2020Q4 OGEN Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
CY2021 OGEN Forgiveness Of Paycheck Protection Program Loan And Accrued Interest
ForgivenessOfPaycheckProtectionProgramLoanAndAccruedInterest
USD

Files In Submission

Name View Source Status
0001493152-22-007664-index-headers.html Edgar Link pending
0001493152-22-007664-index.html Edgar Link pending
0001493152-22-007664.txt Edgar Link pending
0001493152-22-007664-xbrl.zip Edgar Link pending
ex10-6.htm Edgar Link pending
ex10-6_001.jpg Edgar Link pending
ex10-7.htm Edgar Link pending
ex10-7_001.jpg Edgar Link pending
ex10-7_002.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
logo_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
ogen-20211231.xsd Edgar Link pending
ogen-20211231_cal.xml Edgar Link unprocessable
ogen-20211231_def.xml Edgar Link unprocessable
ogen-20211231_lab.xml Edgar Link unprocessable
ogen-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending